Longitudinal single-cell analyses of B cells from people with early MS identify peripheral enrichment of atypical B cells expressing CXCR3, immune checkpoint molecules, and an EBV-associated pro-inflammatory phenotype linked with subsequent disease activity. Here, CXCR3 is linked to myeloid sarcoma.